Baden-Württemberg
News Category

MEDICLIN Posts Stable Nine-Month Results, Confirms 2026 Forecast Despite Challenging Market
MEDICLIN Aktiengesellschaft reported a 4.1% rise in group operating result to EUR 585.9 million and higher EBIT for the first nine months of 2026, con...

hep global Returns to Positive EBIT as Revenue Jumps 72% in First Half of 2026
hep global reported a 72% revenue increase to EUR 17.2 million and a positive EBIT of EUR 0.3 million for the first half of 2026, driven by German sol...

PFISTERER Completes Conversion to Registered Shares, Enhancing Shareholder Transparency
PFISTERER Holding SE has successfully converted its shares from bearer to registered form, a move that grants the company greater visibility into its ...

Germany's EV Subsidy Program Surpasses 100,000 Households, Signaling Strong Consumer Demand
Germany's electric vehicle subsidy program has attracted over 100,000 households, doubling in a month, with implications for automakers and the EV mar...

SLR Group Reports 10% Sales Growth in Fiscal Year 25/26, Forecasts Higher Earnings for 26/27
SLR Group's audited results show a 10% rise in net sales to EUR 213.3 million and a slight increase in adjusted EBITDA, with the company targeting sig...

CENIT AG Supervisory Board Elects New Leadership to Drive Growth Agenda
CENIT AG's Supervisory Board has elected Klaus Weinmann as Chairman and Uwe Kemm as Vice Chairman after court appointments, positioning the company fo...

Schweizer Electronic AG Moves to Scale Segment of Frankfurt Stock Exchange
Schweizer Electronic AG transitions from the regulated market to the Scale segment of the Frankfurt Stock Exchange, aiming to reduce regulatory burden...

hep global Advances Largest German Solar Project to Construction Phase
hep global has completed development of its largest German solar park, a 35.7 MWp project in Eppingen that will generate enough renewable energy to po...

R. STAHL AG Appoints Elke Eckstein to Supervisory Board, Restoring Full Strength
R. STAHL AG has appointed Elke Eckstein to its Supervisory Board, effective immediately, ensuring the board remains fully operational until the next A...

Hep Global Appoints Martin Vogt as CEO in Planned Leadership Transition
Hep Global has promoted Martin Vogt to CEO, succeeding founder Christian Hamann, who becomes CFO, in a move that ensures continuity for the solar proj...

Elring Expands Elring Garage Platform to Support Workshops Amid Evolving Vehicle Technology
Elring announces enhancements to its Elring Garage platform at Automechanika 2026, aiming to equip repair shops with technical knowledge, training, an...

DATAGROUP Lowers Fiscal 2025/2026 Forecast Amid Strategic Investments
DATAGROUP SE revises its annual guidance downward due to a subdued market and one-time costs from strategic measures, expecting flat revenue and lower...

MEDICLIN Reports Solid First Half of 2026 with Revenue and EBIT Growth
MEDICLIN's first-half 2026 results show consolidated revenues up 5% to EUR 386.4 million and EBIT rising to EUR 26.6 million, driven by stability in c...

SAF-HOLLAND Names Alexandre Charpiot as President of EMEA Region
SAF-HOLLAND has appointed Alexandre Charpiot as President EMEA, effective September 1, 2026, succeeding Christoph Gunter who is leaving the group.

DATAGROUP Wins Dataport Service Desk Contract, Bolstering Public Sector Presence
DATAGROUP has secured a five-year contract with Dataport to manage its User Help Desk, strengthening its role as a digitalization partner for German p...

FUCHS SE Nominates Maike Schuh for Supervisory Board, Succession Planned for 2027
FUCHS SE has nominated Maike Schuh for election to its Supervisory Board at the 2027 Annual General Meeting, succeeding Ingeborg Neumann, bringing dee...

VERAXA Biotech Advances Lead T-Cell Engager Program with Cell Line Development Partnership
VERAXA Biotech has initiated cell line development for its lead BiTAC T-cell engager in collaboration with ATUM, advancing the candidate toward IND/CT...

VERAXA Biotech Advances Lead BiTAC T-Cell Engager Program with Cell Line Development Partnership
VERAXA Biotech has initiated cell line development for its lead BiTAC T-cell engager program in partnership with ATUM, a key step toward clinical tria...

hep global Returns to Profitability in Fiscal Year 2025, Eyes Growth in 2026
hep global GmbH reported a significant turnaround in fiscal year 2025 with a positive consolidated result of EUR 2.9 million, driven by a focus on sol...

Medios AG Closes Aschaffenburg Facility to Optimize Manufacturing Network Amid Margin Pressure
Medios AG is closing its Aschaffenburg plant and consolidating production to improve profitability, affecting 32 employees, as regulatory price adjust...

BOS GmbH & Co. KG Bonds Admitted to Trading on Luxembourg Stock Exchange
BOS GmbH & Co. KG's EUR 150 million senior secured bonds have been admitted to trading on the Luxembourg Stock Exchange, providing increased liquidity...

Veraxa Biotech Expands Heidelberg R&D Facilities to Accelerate Cancer Therapy Development
Veraxa Biotech has expanded its R&D footprint in Heidelberg, Germany, to support the advancement of its novel cancer therapy pipeline, including BiTAC...
